| Year |
Citation |
Score |
| 2001 |
Pariser D, Van Den Berg A. Teaching art versus teaching taste: What art teachers can learn from looking at a cross-cultural evaluation of children's art Poetics. 29: 331-350. DOI: 10.1016/S0304-422X(01)00032-8 |
0.316 |
|
| 1991 |
Pariser D. Normal and Unusual Aspects of Juvenile Artistic Development in Klee, Lautrec, and Picasso Creativity Research Journal. 4: 51-65. DOI: 10.1080/10400419109534373 |
0.304 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1997 |
Pariser D. Conceptions of Children's Artistic Giftedness from Modern and Postmodern Perspectives The Journal of Aesthetic Education. 31: 35. DOI: 10.2307/3333142 |
0.298 |
|
| 2002 |
Rostan SM, Pariser D, Gruber HE. A Cross-cultural Study of the Development of Artistic Talent, Creativity and Giftedness High Ability Studies. 13: 124-155. DOI: 10.1080/1359813022000048789 |
0.278 |
|
| 1999 |
Pariser D. Children of Kronos: What Two Artists and Two Cultures Did with Their Childhood Art The Journal of Aesthetic Education. 33: 62. DOI: 10.2307/3333738 |
0.258 |
|
| 1995 |
Pariser D. Not under the lamppost : piagetian and neo-piagetian research in the arts. A review and critique The Journal of Aesthetic Education. 29: 93-108. DOI: 10.2307/3333544 |
0.258 |
|
| 2016 |
Pariser D, Castro JC, Lalonde M. Mobilities, aesthetics and civic engagement: Getting at-risk youth to look at their communities International Journal of Education Through Art. 12: 211-225. DOI: 10.1386/Eta.12.2.211_1 |
0.252 |
|
| 2016 |
Castro JC, Lalonde M, Pariser D. Understanding the (Im)Mobilities of Engaging At-Risk Youth through Art and Mobile Media. Studies in Art Education: a Journal of Issues and Research in Art Education. 57: 238-251. DOI: 10.1080/00393541.2016.1176783 |
0.25 |
|
| 1988 |
Pariser D. Review of Michael Parsons's "How We Understand Art" The Journal of Aesthetic Education. 22: 93. DOI: 10.2307/3332985 |
0.246 |
|
| 1994 |
Pariser D. Comments on Golomb's Book The Journal of Aesthetic Education. 28: 55. DOI: 10.2307/3333269 |
0.243 |
|
| 2014 |
Pariser D. Coping with Flying Sandwiches: Where's the Educational Theory?. Studies in Art Education: a Journal of Issues and Research in Art Education. 55: 300-312. DOI: 10.1080/00393541.2014.11518939 |
0.238 |
|
| 2016 |
Lalonde M, Castro JC, Pariser D. Identity Tableaux: Multimodal Contextual Constructions of Adolescent Identity Visual Arts Research. 42: 38-55. DOI: 10.5406/Visuartsrese.42.1.0038 |
0.226 |
|
| 2001 |
Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children Journal of the American Academy of Dermatology. 44. PMID 11145796 DOI: 10.1067/mjd.2001.109812 |
0.212 |
|
| 2009 |
Leung DYM, Hanifin JM, Pariser DM, Barber KA, Langley RG, Schlievert PM, Abrams B, Hultsch T. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: A randomized, multicentre vehicle-controlled trial British Journal of Dermatology. 161: 435-443. PMID 19416245 DOI: 10.1111/J.1365-2133.2009.09145.X |
0.188 |
|
| 2018 |
Tyring SK, Kircik LH, Pariser DM, Guenin E, Bhatt V, Pillai R. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older. Journal of Drugs in Dermatology : Jdd. 17: 1084-1091. PMID 30365589 |
0.188 |
|
| 2018 |
Stein Gold L, Kircik LH, Pariser D, Sugarman JL, Lin T, Kang R, Pillai R. Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination. Journal of Drugs in Dermatology : Jdd. 17: 863-868. PMID 30124725 |
0.187 |
|
| 2018 |
Bhatia ND, Pariser DM, Kircik L, Lin T, Harris S, Mathew L, Pillai R. Safety and Efficacy of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination Lotion in the Treatment of Moderate-to-severe Plaque Psoriasis: A Comparison with Halobetasol Propionate 0.05% Cream. The Journal of Clinical and Aesthetic Dermatology. 11: 15-19. PMID 30588269 |
0.186 |
|
| 2016 |
Vlahovic TC, Joseph WS, Scher RK, Tosti A, Plasencia J, Pariser DM, Markinson BC. Diagnosis and Management of Onychomycosis Perspectives from a Joint Podiatric Medicine-Dermatology Roundtable. Journal of the American Podiatric Medical Association. 106: 155-62. PMID 27031556 DOI: 10.7547/14-170 |
0.186 |
|
| 2015 |
Markinson BC, Vlahovic TC, Joseph WS, Scher RK, Tosti A, Plasencia J, Pariser DM. Diagnosis and Management of Onychomycosis: Perspectives from a Joint Podiatry-Dermatology Roundtable. Journal of the American Podiatric Medical Association. PMID 26406281 DOI: 10.7547/14-170.1 |
0.186 |
|
| 2019 |
Pariser DM, Kircik LH, Stein Gold LF. Treating psoriasis: patient assessment, treatment goals, and treatment options. Cutis. 103: S4-S7. PMID 31116804 |
0.185 |
|
| 2022 |
Pariser DM. Approaches to Field Therapy for Actinic Keratoses: Relating Clinical Trial Results to Real-world Practice-A Commentary. The Journal of Clinical and Aesthetic Dermatology. 15: 40-43. PMID 35465033 |
0.184 |
|
| 1997 |
Tschen E, Elewski B, Gorsulowsky DC, Pariser DM. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream Journal of the American Academy of Dermatology. 36. PMID 9039199 DOI: 10.1016/S0190-9622(97)70316-5 |
0.184 |
|
| 2019 |
Pariser DM, Green LJ, Lain EL, Schmitz C, Chinigo AS, McNamee B, Berk DR. Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study. The Journal of Clinical and Aesthetic Dermatology. 12: E53-E62. PMID 32038757 |
0.182 |
|
| 2017 |
Sugarman JL, Gold LS, Lebwohl MG, Pariser DM, Alexander BJ, Pillai R. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis. Journal of Drugs in Dermatology : Jdd. 16: 197-204. PMID 28301614 |
0.182 |
|
| 2000 |
Guenther LC, Poulin YP, Pariser DM. A comparison of tazarotene 0.1% Gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis Clinical Therapeutics. 22: 1225-1238. PMID 11110233 DOI: 10.1016/S0149-2918(00)83065-9 |
0.181 |
|
| 2018 |
Gold LS, Lebwohl MG, Sugarman JL, Pariser DM, Lin T, Martin G, Pillai R, Israel R, Ramakrishna T. Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of two Phase 3 randomized controlled trials. Journal of the American Academy of Dermatology. PMID 29614243 DOI: 10.1016/j.jaad.2018.03.040 |
0.181 |
|
| 2008 |
Pariser D, Colón LE, Johnson LA, Gottschalk RW. Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris. Journal of Drugs in Dermatology : Jdd. 7: s18-23. PMID 18575222 |
0.18 |
|
| 2007 |
Glaser DA, Hebert AA, Pariser DM, Solish N. Primary focal hyperhidrosis: scope of the problem. Cutis. 79: 5-17. PMID 17596096 |
0.179 |
|
| 2019 |
Elewski B, Alexis AF, Lebwohl M, Gold LS, Pariser D, Del Rosso J, Yosipovitch G. Itch: An Under-recognized Problem in Psoriasis. Journal of the European Academy of Dermatology and Venereology : Jeadv. PMID 30680819 DOI: 10.1111/jdv.15450 |
0.178 |
|
| 2014 |
Pariser DM, Ballard A. Iontophoresis for palmar and plantar hyperhidrosis. Dermatologic Clinics. 32: 491-4. PMID 25152342 DOI: 10.1016/j.det.2014.06.009 |
0.176 |
|
| 2005 |
Torok H, Taylor S, Baumann L, Jones T, Wieder J, Lowe N, Jarret M, Rich P, Pariser D, Tschen E, Martin D, Menter A, Weiss J. A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads. Journal of Drugs in Dermatology : Jdd. 4: 592-7. PMID 16167418 |
0.176 |
|
| 2009 |
Pariser D. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption. American Journal of Therapeutics. 16: 264-73. PMID 19262357 DOI: 10.1097/MJT.0b013e31818a975c |
0.174 |
|
| 2005 |
Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis. The Journal of Dermatological Treatment. 16: 142-8. PMID 16096179 DOI: 10.1080/09546630510033159 |
0.174 |
|
| 2010 |
Pariser D, Bucko A, Fried R, Jarratt MT, Kempers S, Kircik L, Lucky AW, Rafal E, Rendon M, Weiss J, Wilson DC, Rossi AB, Ramaswamy R, Nighland M. Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening regimen. Journal of Drugs in Dermatology : Jdd. 9: 805-13. PMID 20677537 |
0.173 |
|
| 2003 |
Taylor SC, Torok H, Jones T, Lowe N, Rich P, Tschen E, Menter A, Baumann L, Wieder JJ, Jarratt MM, Pariser D, Martin D, Weiss J, Shavin J, Ramirez N. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis. 72: 67-72. PMID 12889718 |
0.171 |
|
| 2015 |
Scher RK, Tosti A, Joseph WS, Vlahovic TC, Plasencia J, Markinson BC, Pariser DM. Onychomycosis Diagnosis and Management: Perspectives from a Joint Dermatology-Podiatry Roundtable. Journal of Drugs in Dermatology : Jdd. 14: 1016-21. PMID 26355622 |
0.17 |
|
| 2007 |
Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, Roelandts R, Wennberg AM, Morton CA. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. Journal of the American Academy of Dermatology. 56: 125-43. PMID 17190630 DOI: 10.1016/j.jaad.2006.06.006 |
0.17 |
|
| 2008 |
Paller AS, Siegfried EC, Langley RG, Gottlieb AB, Pariser D, Landells I, Hebert AA, Eichenfield LF, Patel V, Creamer K, Jahreis A. Etanercept treatment for children and adolescents with plaque psoriasis. The New England Journal of Medicine. 358: 241-51. PMID 18199863 DOI: 10.1056/NEJMoa066886 |
0.168 |
|
| 2017 |
Pariser D, Frankel E, Schlessinger J, Poulin Y, Vender R, Langley RG, Meng X, Guana A, Nyirady J. Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies. Dermatology and Therapy. PMID 29218492 DOI: 10.1007/s13555-017-0211-4 |
0.168 |
|
| 2019 |
Alexis AF, Rendon M, Silverberg JI, Pariser DM, Lockshin B, Griffiths CE, Weisman J, Wollenberg A, Chen Z, Davis JD, Li M, Eckert L, Gadkari A, Shumel B, Rossi AB, et al. Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials Journal of Drugs in Dermatology : Jdd. 18: 804-813. PMID 31424712 |
0.167 |
|
| 2003 |
Pariser DM. Improving the standard of care for patients with psoriasis. Managed Care (Langhorne, Pa.). 12: 18-20; discussion 20. PMID 18567144 |
0.166 |
|
| 2018 |
Pariser DM, Green LJ, Stein Gold L, Sugarman JL, Lin T, Pillai R. Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy. Journal of Drugs in Dermatology : Jdd. 17: 723-726. PMID 30005093 |
0.166 |
|
| 2013 |
Kimball AB, Pariser D, Yamauchi PS, Menter A, Teller CF, Shi Y, Yong M, Creamer K, Hooper M, Aras G, Kricorian G, Gelfand JM. OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasis. Journal of the American Academy of Dermatology. 68: 756-64. PMID 23357569 DOI: 10.1016/J.Jaad.2012.10.055 |
0.166 |
|
| 2010 |
Landells I, Paller AS, Pariser D, Kricorian G, Foehl J, Molta C, Freundlich B. Efficacy and safety of etanercept in children and adolescents aged > or = 8 years with severe plaque psoriasis. European Journal of Dermatology : Ejd. 20: 323-8. PMID 20185386 DOI: 10.1684/ejd.2010.0911 |
0.166 |
|
| 2021 |
Lebwohl MG, Stein Gold L, Papp K, Han G, Pariser DM, Lin T, Harris S, Jacobson A. Long-Term Safety and Efficacy of a Fixed Combination Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion in Moderate-to-Severe Plaque Psoriasis: Phase 3 Open-Label Study. Journal of the European Academy of Dermatology and Venereology : Jeadv. PMID 33428282 DOI: 10.1111/jdv.17113 |
0.165 |
|
| 2017 |
Boguniewicz M, Alexis AF, Beck LA, Block J, Eichenfield LF, Fonacier L, Guttman-Yassky E, Paller AS, Pariser D, Silverberg JI, Lebwohl M. Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies. The Journal of Allergy and Clinical Immunology. in Practice. PMID 28970084 DOI: 10.1016/j.jaip.2017.08.005 |
0.165 |
|
| 2019 |
Lebwohl M, Alexis AF, Beck LA, Block JK, Eichenfield LF, Fonacier L, Guttman-Yassky E, Paller AS, Pariser D, Silverberg JI, Boguniewicz M. Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice Journal of Drugs in Dermatology : Jdd. 18: 122-129. PMID 30794360 |
0.164 |
|
| 2010 |
Pariser D. Adapalene 0.1% and benzoyl peroxide 2.5% combination gel for the treatment of acne vulgaris Expert Review of Dermatology. 5: 385-391. DOI: 10.1586/edm.10.32 |
0.164 |
|
| 2020 |
Hebert AA, Glaser DA, Green L, Hull C, Cather J, Drew J, Gopalan R, Pariser DM. Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study. Pediatric Dermatology. PMID 32147881 DOI: 10.1111/pde.14135 |
0.163 |
|
| 2013 |
Pariser D, Scher RK, Elewski B, Rich P. Promoting and maintaining or restoring healthy nails: practical recommendations for clinicians and patients. Seminars in Cutaneous Medicine and Surgery. 32: S13-4. PMID 24156163 |
0.162 |
|
| 2015 |
Papp K, Gottlieb AB, Naldi L, Pariser D, Ho V, Goyal K, Fakharzadeh S, Chevrier M, Calabro S, Langholff W, Krueger G. Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR). Journal of Drugs in Dermatology : Jdd. 14: 706-14. PMID 26151787 |
0.161 |
|
| 2005 |
Breneman D, Fleischer AB, Kaplan D, Lebwohl M, Miller B, Pariser D, Rist T, Swinyer L, Liu Y, Foley V. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream. Journal of Drugs in Dermatology : Jdd. 4: 330-6. PMID 15898289 |
0.161 |
|
| 2016 |
Paller AS, Siegfried EC, Pariser DM, Rice KC, Trivedi M, Iles J, Collier DH, Kricorian G, Langley RG. Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis. Journal of the American Academy of Dermatology. 74: 280-287.e3. PMID 26775775 DOI: 10.1016/j.jaad.2015.09.056 |
0.16 |
|
| 2021 |
Zeitouni NC, Bhatia N, Ceilley RI, Cohen JL, Del Rosso JQ, Moore AY, Munavalli G, Pariser DM, Schlesinger T, Siegel DM, Willey A, Goldman MP. Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices. The Journal of Clinical and Aesthetic Dermatology. 14: E53-E65. PMID 34976292 |
0.158 |
|
| 1990 |
Pariser DM. Cutaneous candidiasis. A practical guide for primary care physicians Postgraduate Medicine. 87: 101-108. PMID 2336415 |
0.158 |
|
| 1995 |
Katz HI, Lindholm JS, Weiss JS, Shavin JS, Morman M, Bressinck R, Cornell R, Pariser DM, Pariser RJ, Weng W, Samsom C. Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis Clinical Therapeutics. 17: 390-401. PMID 7585843 DOI: 10.1016/0149-2918(95)80104-9 |
0.157 |
|
| 2018 |
Hebert AA, Glaser DA, Green L, Werschler WP, Forsha DW, Drew J, Gopalan R, Pariser DM. Short- and Long-Term Efficacy and Safety of Glycopyrronium Cloth for the Treatment of Primary Axillary Hyperhidrosis: Post Hoc Pediatric Subgroup Analyses from the Phase 3 Studies Skin the Journal of Cutaneous Medicine. 2: S68. DOI: 10.25251/SKIN.2.SUPP.68 |
0.157 |
|
| 2015 |
Papp K, Pariser D, Catlin M, Wierz G, Ball G, Akinlade B, Zeiher B, Krueger JG. A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis British Journal of Dermatology. 173: 767-776. DOI: 10.1111/bjd.13745 |
0.157 |
|
| 2014 |
Pariser DM, Ballard A. Topical therapies in hyperhidrosis care. Dermatologic Clinics. 32: 485-90. PMID 25152341 DOI: 10.1016/j.det.2014.06.008 |
0.156 |
|
| 2020 |
Kirsch B, Smith S, Cohen J, DuBois J, Green L, Baumann L, Bhatia N, Pariser D, Liu PY, Chadha D, Walker P. Efficacy and Safety of Topical Sofpironium Bromide Gel for the Treatment of Axillary Hyperhidrosis: A Phase II, Randomized, Controlled, Double-Blinded Trial. Journal of the American Academy of Dermatology. PMID 32068049 DOI: 10.1016/j.jaad.2020.02.016 |
0.155 |
|
| 2023 |
Zirwas MJ, Draelos ZD, DuBois J, Kircik LH, Moore AY, Stein Gold L, Alonso-Llamazares J, Bukhalo M, Bruce S, Eads K, Green LJ, Guenthner ST, Ferris LK, Forman SB, Kempers SE, ... ... Pariser DM, et al. Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial. Jama Dermatology. PMID 37133856 DOI: 10.1001/jamadermatol.2023.0846 |
0.154 |
|
| 2013 |
Lebwohl MG, Kircik L, Callis Duffin K, Pariser D, Hooper M, Wenkert D, Thompson EH, Yang J, Kricorian G, Koo J. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology. 69: 385-92. PMID 23643256 DOI: 10.1016/j.jaad.2013.03.031 |
0.153 |
|
| 2018 |
Hebert AA, Glaser DA, Green L, Werschler WP, Forsha DW, Drew J, Gopalan R, Pariser DM. Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials. Pediatric Dermatology. PMID 30451318 DOI: 10.1111/pde.13723 |
0.153 |
|
| 2005 |
Koo JY, Fleischer AB, Abramovits W, Pariser DM, McCall CO, Horn TD, Gottlieb AB, Jaracz E, Rico MJ. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients. Journal of the American Academy of Dermatology. 53: S195-205. PMID 16021175 DOI: 10.1016/j.jaad.2005.04.063 |
0.152 |
|
| 2021 |
Stein Gold L, Baldwin H, Kircik LH, Weiss JS, Pariser DM, Callender V, Lain E, Gold M, Beer K, Draelos Z, Sadick N, Pillai R, Bhatt V, Tanghetti EA. Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug. American Journal of Clinical Dermatology. PMID 34674160 DOI: 10.1007/s40257-021-00650-3 |
0.152 |
|
| 2016 |
Menter MA, Papp KA, Cather J, Leonardi C, Pariser DM, Krueger JG, Wohlrab J, Amaya-Guerra M, Kaszuba A, Nadashkevich O, Tsai TF, Gupta P, Tan H, Valdez H, Mallbris L, et al. Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials. Journal of Drugs in Dermatology : Jdd. 15: 568-80. PMID 27168266 |
0.151 |
|
| 2016 |
Bissonnette R, Pariser DM, Wasel NR, Goncalves J, Day RM, Chen R, Sebastian M. Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis. Journal of the American Academy of Dermatology. PMID 27021239 DOI: 10.1016/j.jaad.2016.02.1164 |
0.15 |
|
| 2020 |
Augustin M, Thaci D, Eyerich K, Pinter A, Radtke M, Lauffer F, Mrowietz U, Gerdes S, Pariser D, Lebwohl M, Sieder C, Melzer N, Reich K. The efficacy of secukinumab with continued use in the treatment of psoriasis British Journal of Dermatology. 182: e22-e22. DOI: 10.1111/bjd.18653 |
0.15 |
|
| 2004 |
Kempers S, Boguniewicz M, Carter E, Jarratt M, Pariser D, Stewart D, Stiller M, Tschen E, Chon K, Wisseh S, Abrams B. A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis. Journal of the American Academy of Dermatology. 51: 515-25. PMID 15389185 DOI: 10.1016/j.jaad.2004.01.051 |
0.149 |
|
| 1994 |
Pariser DM, Pariser RJ. Oxiconazole nitrate lotion, 1 percent: An effective treatment for tinea pedis Cutis. 54: 43-44. PMID 7924451 |
0.148 |
|
| 2010 |
Paller AS, Siegfried EC, Eichenfield LF, Pariser D, Langley RG, Creamer K, Kricorian G. Long-term etanercept in pediatric patients with plaque psoriasis. Journal of the American Academy of Dermatology. 63: 762-8. PMID 20605256 DOI: 10.1016/j.jaad.2010.04.004 |
0.148 |
|
| 2019 |
Glaser DA, Hebert AA, Nast A, Werschler WP, Green L, Mamelok RD, Quiring J, Drew J, Pariser DM. A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis. American Journal of Clinical Dermatology. PMID 31111409 DOI: 10.1007/s40257-019-00446-6 |
0.148 |
|
| 2018 |
Glaser DA, Hebert A, Pieretti L, Pariser D. Understanding Patient Experience With Hyperhidrosis: A National Survey of 1,985 Patients. Journal of Drugs in Dermatology : Jdd. 17: 392-396. PMID 29601615 |
0.148 |
|
| 2017 |
Hanke CW, Berman B, Swanson N, Pariser DM, Weiss JS, Bukhalo M, Skov T, Villumsen J, Siegel D. Safety and Efficacy of Escalating Doses of Ingenol Mebutate for Field Treatment of Actinic Keratosis on the Full Face, Full Balding Scalp, or Chest. Journal of Drugs in Dermatology : Jdd. 16: 438-444. PMID 28628679 |
0.147 |
|
| 2007 |
Glaser DA, Hebert AA, Pariser DM, Solish N. Palmar and plantar hyperhidrosis: best practice recommendations and special considerations. Cutis. 79: 18-28. PMID 17596097 |
0.147 |
|
| 2019 |
Simpson EL, Paller AS, Siegfried EC, Boguniewicz M, Sher L, Gooderham MJ, Beck LA, Guttman-Yassky E, Pariser D, Blauvelt A, Weisman J, Lockshin B, Hultsch T, Zhang Q, Kamal MA, et al. Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial. Jama Dermatology. PMID 31693077 DOI: 10.1001/jamadermatol.2019.3336 |
0.146 |
|
| 2022 |
Strober B, Fox J, Jekowsky E, Pariser D, Schaecher K. Evidence Threshold for a Precision Medicine Test that Predicts Optimal Response to a Biologic Agent in Patients With Psoriasis: A Consensus Panel. Journal of Drugs in Dermatology : Jdd. 21: 630-636. PMID 35674756 DOI: 10.36849/JDD.6864 |
0.146 |
|
| 2005 |
Pariser DM, Thiboutot DM, Clark SD, Jones TM, Liu Y, Graeber M. The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle. Cutis. 76: 145-51. PMID 16209161 |
0.145 |
|
| 1991 |
Pariser DM. Topical steroids: A guide for use in the elderly patient Geriatrics. 46: 51-52+54+57. PMID 1916302 |
0.145 |
|
| 2016 |
Gupta AK, Elewski BE, Rosen T, Caldwell B, Pariser DM, Kircik LH, Bhatia N, Tosti A. Onychomycosis: Strategies to Minimize Recurrence. Journal of Drugs in Dermatology : Jdd. 15: 279-82. PMID 26954312 |
0.145 |
|
| 2004 |
Gribetz C, Ling M, Lebwohl M, Pariser D, Draelos Z, Gottlieb AB, Zaias N, Chen DM, Parneix-Spake A, Hultsch T, Menter A. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study. Journal of the American Academy of Dermatology. 51: 731-8. PMID 15523351 DOI: 10.1016/j.jaad.2004.06.010 |
0.145 |
|
| 2024 |
Zouboulis CC, Passeron T, Pariser D, Wozniak MB, Li X, Uhlmann L, Lobach I, Martinez AL, Ravichandran S, Alarcon I, Offidani A, Alam MS, Mendes-Bastos P. Secukinumab in patients with moderate to severe hidradenitis suppurativa based on prior biologic exposure: An efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials. The British Journal of Dermatology. PMID 38470171 DOI: 10.1093/bjd/ljae098 |
0.145 |
|
| 2006 |
Nestor MS, Gold MH, Kauvar AN, Taub AF, Geronemus RG, Ritvo EC, Goldman MP, Gilbert DJ, Richey DF, Alster TS, Anderson RR, Bank DE, Carruthers A, Carruthers J, Goldberg DJ, ... ... Pariser DM, et al. The use of photodynamic therapy in dermatology: results of a consensus conference. Journal of Drugs in Dermatology : Jdd. 5: 140-54. PMID 16485882 |
0.144 |
|
| 2021 |
Gold LS, Papp K, Pariser D, Green L, Bhatia N, Sofen H, Albrecht L, Gooderham M, Chen M, Paris M, Wang Y, Callis Duffin K. EFFICACY AND SAFETY OF APREMILAST IN PATIENTS WITH MILD TO MODERATE PLAQUE PSORIASIS: RESULTS OF A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. Journal of the American Academy of Dermatology. PMID 34343599 DOI: 10.1016/j.jaad.2021.07.040 |
0.143 |
|
| 2004 |
Belsito DV, Fowler JF, Marks JG, Pariser DM, Hanifin J, Duarte IA, Pires MC, Cruz PD, Langley RG, Patel P, Bush C, Thurston M, Graeber M, Cherill R. Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis. 73: 31-8. PMID 14964629 |
0.143 |
|
| 2018 |
Glaser DA, Hebert AA, Nast A, Werschler WP, Green L, Mamelok R, Drew J, Quiring J, Pariser DM. Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 Phase 3 Randomized Controlled Trials. Journal of the American Academy of Dermatology. PMID 30003988 DOI: 10.1016/j.jaad.2018.07.002 |
0.143 |
|
| 2015 |
Pariser DM. Efficacy and Safety of Onychomycosis Treatments: An Evidence-Based Overview. Seminars in Cutaneous Medicine and Surgery. 34: S46-S50. PMID 26624988 DOI: 10.12788/j.sder.2015.0148 |
0.143 |
|
| 2006 |
Pariser DM. Clinical considerations for the treatment of hyperhidrosis: Case reports Cutis. 77: 47-51. |
0.142 |
|
| 2023 |
Thaçi D, Vender R, de Rie MA, Conrad C, Pariser DM, Strober B, Vanvoorden V, Wang M, Madden C, de Cuyper D, Kimball AB. Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial. The British Journal of Dermatology. 188: 22-31. PMID 36689515 DOI: 10.1093/bjd/ljac021 |
0.142 |
|
| 2015 |
Leonardi C, Bagel J, Yamauchi P, Pariser D, Xu Z, Olesen M, Osterdal ML, Stein Gold L. Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris - a Randomized Phase III Study (PSO-FAST). Journal of Drugs in Dermatology : Jdd. 14: 1468-77. PMID 26659941 |
0.142 |
|
| 2019 |
Stein Gold L, Pariser DM, Guenin E. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability Journal of Drugs in Dermatology : Jdd. 18: 1218-1225. PMID 31860209 |
0.142 |
|
| 2019 |
Stein Gold LF, Kircik LH, Pariser DM. Understanding topical therapies for psoriasis. Cutis. 103: S8-S12. PMID 31116805 |
0.141 |
|
| 2016 |
Eichenfield LF, Gold LS, Nahm WK, Cook-Bolden FE, Pariser DM. Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne Vulgaris. Journal of Drugs in Dermatology : Jdd. 15: 1496-15027. PMID 28095573 |
0.141 |
|
| 2020 |
Lebwohl MG, Sugarman J, Pariser DM, Bagel J, Trickett C, Jacobson A, Israel R. Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study Skin the Journal of Cutaneous Medicine. 4: s38. DOI: 10.25251/SKIN.4.SUPP.38 |
0.141 |
|
| 2007 |
Lebwohl M, Menter A, Weiss J, Clark SD, Flores J, Powers J, Balin AK, Kempers S, Glinert RJ, Fleming T, Liu Y, Graeber M, Pariser DM. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies. Journal of Drugs in Dermatology : Jdd. 6: 428-35. PMID 17668541 |
0.141 |
|
| 2018 |
Pariser DM, Hebert AA, Drew J, Quiring J, Gopalan R, Glaser DA. Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials. American Journal of Clinical Dermatology. PMID 30378087 DOI: 10.1007/s40257-018-0395-0 |
0.14 |
|
| 2015 |
Wirta D, Pariser DM, Yoelin SG, Arase S, McMichael A, Weng E, Mao C, Demos G, Vandenburgh A. Bimatoprost 0.03% for the Treatment of Eyelash Hypotrichosis: A Pooled Safety Analysis of Six Randomized, Double-masked Clinical Trials. The Journal of Clinical and Aesthetic Dermatology. 8: 17-29. PMID 26203317 |
0.14 |
|
| 2017 |
Blauvelt A, de Bruin-Weller M, Gooderham M, Cather JC, Weisman J, Pariser D, Simpson EL, Papp KA, Hong HC, Rubel D, Foley P, Prens E, Griffiths CEM, Etoh T, Pinto PH, et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet (London, England). PMID 28478972 DOI: 10.1016/S0140-6736(17)31191-1 |
0.14 |
|
| 2004 |
Gordon K, Pariser D, Langley R, Caro I. Efficacy and safety of efalizumab in a large cohort of patients with moderate to severe plaque psoriasis: pooled results from randomized phase III trials Journal of the American Academy of Dermatology. 50: P1. DOI: 10.1016/J.JAAD.2003.10.010 |
0.138 |
|
| 2016 |
Leonardi C, Bagel J, Yamauchi P, Pariser D, Xu Z, Moller A, Osterdal ML, Gold LS. The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients With Psoriasis Vulgaris: Results from the Randomized PSO-FAST Study. Journal of Drugs in Dermatology : Jdd. 15: 981-987. PMID 27537999 |
0.138 |
|
| 2015 |
Papp K, Gottlieb AB, Naldi L, Pariser D, Ho V, Goyal K, Fakharzadeh S, Chevrier M, Calabro S, Langholff W, Krueger G. Safety surveillance for ustekinumab and other psoriasis treatments from the psoriasis longitudinal assessment and (PSOLAR) Journal of Drugs in Dermatology. 14: 706-714. |
0.138 |
|
| 2019 |
Nelson LM, DiBenedetti D, Pariser DM, Glaser DA, Hebert AA, Hofland H, Drew J, Ingolia D, Gillard KK, Fehnel S. Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity. Journal of Patient-Reported Outcomes. 3: 59. PMID 31486951 DOI: 10.1186/S41687-019-0148-8 |
0.138 |
|
| 2019 |
Kircik LH, Stein Gold LF, Pariser DM. Improving Adherence to Topical Therapies Through Improved Clinician-Patient Communication and Shared Decision Making. Cutis. 103: S13-S15. PMID 31116806 |
0.138 |
|
| 2015 |
Eichenfield LF, Del Rosso JQ, Mancini AJ, Cook-Bolden F, Stein Gold L, Desai S, Weiss J, Pariser D, Zeichner J, Bhatia N, Kircik L. Evolving perspectives on the etiology and pathogenesis of acne vulgaris. Journal of Drugs in Dermatology : Jdd. 14: 263-72. PMID 25738848 |
0.137 |
|
| 2020 |
Pariser DM, Green LJ, Lain EL, Schmitz C, Chinigo AS, McNames B, Berk DR, Hoffman J, Grada A. Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris Skin the Journal of Cutaneous Medicine. 4: s53. DOI: 10.25251/skin.4.supp.52 |
0.137 |
|
| 2013 |
Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H, Ieda C, Smith K, Pillai R, Ramakrishna T, Olin JT. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies. Journal of the American Academy of Dermatology. 68: 600-8. PMID 23177180 DOI: 10.1016/j.jaad.2012.10.013 |
0.137 |
|
| 2014 |
Pariser DM, Rich P, Cook-Bolden FE, Korotzer A. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris. Journal of Drugs in Dermatology : Jdd. 13: 1083-9. PMID 25226009 |
0.137 |
|
| 2012 |
Pariser DM, Leonardi CL, Gordon K, Gottlieb AB, Tyring S, Papp KA, Li J, Baumgartner SW. Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasis. Journal of the American Academy of Dermatology. 67: 245-56. PMID 22015149 DOI: 10.1016/j.jaad.2011.07.040 |
0.136 |
|
| 2005 |
Pariser DM, Gordon KB, Papp KA, Leonardi CL, Kwon P, Compton PG, Rundle AC, Walicke PA, Lebwohl M. Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part I. Journal of Cutaneous Medicine and Surgery. 9: 303-12. PMID 16699904 DOI: 10.1007/s10227-005-0116-1 |
0.136 |
|
| 2011 |
Hanke CW, Rohrich RJ, Busso M, Carruthers A, Carruthers J, Fagien S, Fitzgerald R, Glogau R, Greenberger PE, Lorenc ZP, Marmur ES, Monheit GD, Pusic A, Rubin MG, Rzany B, ... ... Pariser DM, et al. Facial Soft-Tissue Fillers: Assessing the State of the Science conference---Proceedings report. Journal of the American Academy of Dermatology. 64: S53-65. PMID 21458678 DOI: 10.1016/j.jaad.2011.02.008 |
0.136 |
|
| 2003 |
Aly R, Fisher G, Katz I, Levine N, Lookingbill DP, Lowe N, Menter A, Morman M, Pariser DM, Roth HL, Savin RC, Shavin JS, Stewart D, Taylor JR, Tucker S, et al. Ciclopirox gel in the treatment of patients with interdigital tinea pedis. International Journal of Dermatology. 42: 29-35. PMID 14567368 |
0.136 |
|
| 2023 |
Zakria D, Brownstone N, Armstrong AW, Boh EE, Koo JYM, Merola JF, Pariser D, Lebwohl M. Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel. Journal of Drugs in Dermatology : Jdd. 22: 588-593. PMID 37276166 DOI: 10.36849/JDD.7432 |
0.135 |
|
| 2020 |
Forman SB, Pariser DM, Poulin Y, Vincent MS, Gilbert SA, Kieras EM, Qiu R, Yu D, Papacharalambous J, Tehlirian C, Peeva E. TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-blind, Placebo-controlled Trial. The Journal of Investigative Dermatology. PMID 32311398 DOI: 10.1016/j.jid.2020.03.962 |
0.135 |
|
| 2019 |
Laquer V, Bruce S, Schlesinger T, Zeitouni N, Torres A, Cohen J, Tu J, Hanke W, Goldman M, Ozog D, Markowitz O, Gold M, Nestor M, Berman B, Munavalli G, ... Pariser D, et al. A randomized, double blind, vehicle-controlled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA and narrowband red light in the treatment of superficial basal cell carcinoma (sBCC) with photodynamic therapy (PDT) Skin the Journal of Cutaneous Medicine. 3: S48. DOI: 10.25251/skin.3.supp.48 |
0.135 |
|
| 2005 |
Staab D, Pariser D, Gottlieb AB, Kaufmann R, Eichenfield LF, Langley RG, Scott G, Ebelin ME, Barilla D, Schmidli H, Burtin P. Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label study. Pediatric Dermatology. 22: 465-71. PMID 16191004 DOI: 10.1111/j.1525-1470.2005.00128.x |
0.134 |
|
| 1990 |
Pariser DM. Superficial fungal infections. A practical guide for primary care physicians Postgraduate Medicine. 87: 205-214. PMID 2138735 |
0.134 |
|
| 2007 |
Glaser DA, Hebert AA, Pariser DM, Solish N. Facial hyperhidrosis: best practice recommendations and special considerations. Cutis. 79: 29-32. PMID 17596098 |
0.134 |
|
| 2006 |
Pariser DM. Importance of patient access to care and insurance reimbursement Cutis. 77: 42-46. |
0.134 |
|
| 2016 |
Pariser DM, Eichenfield LF, Bukhalo M, Waterman G, Jarratt M. Photodynamic therapy with methyl aminolaevulinate 80 mg g-1 for severe facial acne vulgaris: A randomized vehicle-controlled study British Journal of Dermatology. DOI: 10.1111/bjd.14345 |
0.133 |
|
| 2001 |
Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, Lowe NJ, Jones TM, Stewart DM, Jarratt MT, Katz I, Pariser DM, Pariser RJ, Tschen E, Chalker DK, et al. Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin Journal of the American Academy of Dermatology. 45: 196-207. PMID 11464180 DOI: 10.1067/mjd.2001.115966 |
0.133 |
|
| 2018 |
Pariser D, Gopalan R, Drew J, Green L. Clinical Management of Anticholinergic Adverse Events with Glycopyrronium Cloth, a Treatment for Primary Axillary Hyperhidrosis Skin the Journal of Cutaneous Medicine. 2: S66. DOI: 10.25251/skin.2.supp.66 |
0.133 |
|
| 2020 |
Gupta AK, Surprenant MS, Kempers SE, Pariser DM, Rensfeldt K, Tavakkol A. Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild-to-moderate distal subungual onychomycosis: A randomized, multi-center, double-blind, vehicle-controlled phase 3 study. Journal of the American Academy of Dermatology. PMID 32585278 DOI: 10.1016/j.jaad.2020.06.055 |
0.132 |
|
| 1990 |
Pariser DM. Tinea versicolor: A practical guide for primary care physicians Postgraduate Medicine. 87: 61-62. PMID 2343018 |
0.132 |
|
| 1998 |
Savin RC, Drake L, Babel D, Stewart DM, Rich P, Ling MR, Breneman D, Scher RK, Martin AG, Pariser DM, Pariser RJ, Ellis CN, Kang S, Friedman D, Katz HI, et al. Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail Journal of the American Academy of Dermatology. 38: S110-S116. PMID 9631993 |
0.131 |
|
| 1999 |
Kaminester LH, Pariser RJ, Pariser DM, Weiss JS, Shayin JS, Landsman L, Haines HG, Osborne DW. A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis Journal of the American Academy of Dermatology. 41: 996-1001. PMID 10570387 |
0.13 |
|
| 2022 |
Pariser D, Rivera E, Benedict D. Open-Label Cohort Study to Evaluate Efficacy and Safety of Application of Glycopyrronium Cloth, 2.4% for Palmar Hyperhidrosis. Journal of Drugs in Dermatology : Jdd. 21: 488-495. PMID 35533035 DOI: 10.36849/JDD.6688 |
0.129 |
|
| 2001 |
Pariser D. Mentor's Introduction Marilyn Zurmuehlen Working Papers in Art Education. 2001. DOI: 10.17077/2326-7070.1362 |
0.129 |
|
| 2005 |
Draelos Z, Nayak A, Pariser D, Shupack JL, Chon K, Abrams B, Paul CF. Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison. Journal of the American Academy of Dermatology. 53: 602-9. PMID 16198779 DOI: 10.1016/j.jaad.2005.06.013 |
0.128 |
|
| 2018 |
Pariser D, Green L, Drew J, Gopalan R, Yan V, Glaser D. Onset of Action With Glycopyrronium Cloth in the Treatment of Primary Axillary Hyperhidrosis Skin the Journal of Cutaneous Medicine. 2: S67. DOI: 10.25251/skin.2.supp.67 |
0.128 |
|
| 2013 |
Brown T, Carter C, Farahi K, Rose A, Fehnel S, Pariser D, Ellis C, Schenkel B. Understanding The Psoriasis Patient Perspective: Using A Combination Of Qualitative And Quantitative Analyses To Explore And Describe Symptoms, Impacts, And Treatment-Related Experiences Across The Course Of Disease Value in Health. 16: A178. DOI: 10.1016/J.JVAL.2013.03.894 |
0.128 |
|
| 2009 |
Foley P, Freeman M, Menter A, Siller G, El-Azhary RA, Gebauer K, Lowe NJ, Jarratt MT, Murrell DF, Rich P, Pariser DM, Oseroff AR, Barnetson R, Anderson C, Kossard S, et al. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies. International Journal of Dermatology. 48: 1236-45. PMID 20064185 DOI: 10.1111/J.1365-4632.2008.04022.X |
0.128 |
|
| 2011 |
Rohrich RJ, Hanke CW, Busso M, Carruthers A, Carruthers J, Fagien S, Fitzgerald R, Glogau R, Greenberger PE, Lorenc ZP, Marmur ES, Monheit GD, Pusic A, Rubin MG, Rzany B, ... ... Pariser DM, et al. Facial soft-tissue fillers conference: assessing the state of the science. Plastic and Reconstructive Surgery. 127: 22S-S. PMID 21490546 DOI: 10.1097/PRS.0b013e31820578d0 |
0.127 |
|
| 2011 |
Hanke CW, Rohrich RJ, Busso M, Carruthers A, Carruthers J, Fagien S, Fitzgerald R, Glogau R, Greenberger PE, Lorenc ZP, Marmur ES, Monheit GD, Pusic A, Rubin MG, Rzany B, ... ... Pariser DM, et al. Facial Soft-Tissue Fillers conference: Assessing the State of the Science. Journal of the American Academy of Dermatology. 64: S66-85, S85.e1-136. PMID 21458679 DOI: 10.1016/j.jaad.2011.02.009 |
0.127 |
|
| 2003 |
Elewski BE, Fleischer AB, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Archives of Dermatology. 139: 1444-50. PMID 14623704 DOI: 10.1001/archderm.139.11.1444 |
0.127 |
|
| 2013 |
Elewski B, Pariser D, Rich P, Scher RK. Current and emerging options in the treatment of onychomycosis. Seminars in Cutaneous Medicine and Surgery. 32: S9-12. PMID 24156162 |
0.127 |
|
| 2022 |
Lebwohl MG, Kircik LH, Moore AY, Stein Gold L, Draelos ZD, Gooderham MJ, Papp KA, Bagel J, Bhatia N, Del Rosso JQ, Ferris LK, Green LJ, Hebert AA, Jones T, Kempers SE, ... Pariser DM, et al. Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials. Jama. 328: 1073-1084. PMID 36125472 DOI: 10.1001/jama.2022.15632 |
0.126 |
|
| 2023 |
Blauvelt A, Pariser DM, Tyring S, Bagel J, Alexis AF, Soung J, Armstrong AW, Muscianisi E, Kianifard F, Steadman J, Sarkar RP, Garcet S, Krueger JG. Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study. Journal of Dermatological Science. PMID 36690571 DOI: 10.1016/j.jdermsci.2023.01.003 |
0.125 |
|
| 2020 |
Tyring SK, Kircik L, Pariser DM, Woolery-Lloyd HC, Harper JC, Bhatt V, Pillai R, Guenin E. The Effects of Once-Daily Tretinoin 0.05% Lotion on Quality of Life in Patients with Moderate-to-Severe Acne Vulgaris. American Journal of Clinical Dermatology. PMID 32886337 DOI: 10.1007/s40257-020-00559-3 |
0.125 |
|
| 2007 |
Pariser DM, Westmoreland P, Morris A, Gold MH, Liu Y, Graeber M. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris. Journal of Drugs in Dermatology : Jdd. 6: 899-905. PMID 17941361 |
0.125 |
|
| 2010 |
Siegfried EC, Eichenfield LF, Paller AS, Pariser D, Creamer K, Kricorian G. Intermittent etanercept therapy in pediatric patients with psoriasis. Journal of the American Academy of Dermatology. 63: 769-74. PMID 20833444 DOI: 10.1016/j.jaad.2009.10.046 |
0.124 |
|
| 2017 |
Schmieder GJ, Draelos ZD, Pariser DM, Banfield C, Cox L, Hodge M, Kieras E, Parsons-Rich D, Menon S, Salganik M, Page K, Peeva E. Efficacy and safety of the Janus Kinase 1 inhibitor PF-04965842 in patients with moderate to severe psoriasis: phase 2, randomized, double-blind, placebo-controlled study. The British Journal of Dermatology. PMID 28949012 DOI: 10.1111/Bjd.16004 |
0.124 |
|
| 2006 |
Tschen EH, Wong DS, Pariser DM, Dunlap FE, Houlihan A, Ferdon MB, Bruce S, Jarratt MT, Loss RW, Weiss J, Shavin JS, Barba A, Zeide DA, Brodell RT. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: Phase IV multicentre clinical trial with 12-month follow up British Journal of Dermatology. 155: 1262-1269. PMID 17107399 DOI: 10.1111/j.1365-2133.2006.07520.x |
0.124 |
|
| 2022 |
Stein Gold L, Alonso-Llamazares J, Draelos ZD, Gooderham MJ, Kempers SE, Kircik LH, Lebwohl MG, Papp KA, Pariser DM, Toth DP, Yosipovitch G, Higham RC, Feng A, Berk DR. Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial. American Journal of Clinical Dermatology. PMID 36370336 DOI: 10.1007/s40257-022-00739-3 |
0.123 |
|
| 1999 |
Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, Hecker D, Kraus S, Baldwin H, Shalita A, Draelos Z, Markou M, Thiboutot D, Rapaport M, Kang S, Kelly T, ... Pariser D, et al. Finasteride in the treatment of men with frontal male pattern hair loss Journal of the American Academy of Dermatology. 40: 930-937. DOI: 10.1016/S0190-9622(99)70081-2 |
0.123 |
|
| 2020 |
Crowley JJ, Pariser DM, Yamauchi PS. A brief guide to pustular psoriasis for primary care providers. Postgraduate Medicine. 1-15. PMID 33118424 DOI: 10.1080/00325481.2020.1831315 |
0.123 |
|
| 2014 |
Pariser DM. Incorporating diagnosis and treatment of hyperhidrosis into clinical practice. Dermatologic Clinics. 32: 565-74. PMID 25152351 DOI: 10.1016/j.det.2014.06.010 |
0.123 |
|
| 2002 |
Pariser D, Opper C. An in-office diagnostic procedure to detect dermatophytes in a nationwide study of onychomycosis patients. Managed Care (Langhorne, Pa.). 11: 43-8, 50. PMID 11928244 |
0.122 |
|
| 2019 |
Brian Jiang SI, Kempers S, Rich P, Marcus S, Houlihan A, Piacquadio D, Pariser D. A Randomized, Vehicle-Controlled Phase 3 Study of Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses on the Upper Extremities. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 30640777 DOI: 10.1097/DSS.0000000000001760 |
0.122 |
|
| 1994 |
Pariser DM, Pariser RJ, Ruoff G, Ray TL. Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea cruris. Journal of the American Academy of Dermatology. 31: 232-4. PMID 8040406 |
0.122 |
|
| 1989 |
Pariser DM. Cutaneous viral infections: Herpes simplex and varicella-zoster Primary Care - Clinics in Office Practice. 16: 577-589. PMID 2678171 |
0.122 |
|
| 2017 |
Gottlieb AB, Strober B, Lebwohl M, Kaufmann R, Pariser D, Narbutas R, Nyirady J, Zhao Y, Herrera V, McLeod L, Odom D, Elewski BE. Greater Efficacy with Secukinumab Treatment is Associated with Greater Psoriasis Symptom Relief: Results from Secukinumab Clinical Trial Data Journal of Psoriasis and Psoriatic Arthritis. 2: 73-80. DOI: 10.1177/247553031700200206 |
0.122 |
|
| 1998 |
Lange DS, Richards HM, Guarnieri J, Humeniuk JM, Savin RC, Reyes BA, Hickman J, Pariser DM, Pariser RJ, Sherertz EF, Grossman RM, Gisoldi EM, Klausner MA. Ketoconazole 2% shampoo in the treatment of tinea versicolor: A multicenter, randomized, double-blind, placebo-controlled trial Journal of the American Academy of Dermatology. 39: 944-950. PMID 9843006 |
0.122 |
|
| 2015 |
Werner RN, Stockfleth E, Connolly SM, Correia O, Erdmann R, Foley P, Gupta AK, Jacobs A, Kerl H, Lim HW, Martin G, Paquet M, Pariser DM, Rosumeck S, Röwert-Huber HJ, et al. Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version. Journal of the European Academy of Dermatology and Venereology : Jeadv. PMID 26370093 DOI: 10.1111/jdv.13180 |
0.121 |
|
| 2022 |
Kim EJ, Mangold AR, DeSimone JA, Wong HK, Seminario-Vidal L, Guitart J, Appel J, Geskin L, Lain E, Korman NJ, Zeitouni N, Nikbakht N, Dawes K, Akilov O, Carter J, ... ... Pariser D, et al. Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial. Jama Dermatology. PMID 35857290 DOI: 10.1001/jamadermatol.2022.2749 |
0.121 |
|
| 2023 |
Draelos ZD, Adam DN, Hong CH, Lebwohl MG, Lynde CW, Nahm WK, Papp KA, Pariser DM, Stein Gold L, Stewart D, Higham RC, Berk DR, Krupa D, Burnett P. Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial. The British Journal of Dermatology. PMID 36890712 DOI: 10.1093/bjd/ljad060 |
0.12 |
|
| 2020 |
Pariser DM, Bagel J, Lebwohl M, Yosipovitch G, Chien E, Spellman MC. Serlopitant for Psoriatic Pruritus: a Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Journal of the American Academy of Dermatology. PMID 32007513 DOI: 10.1016/j.jaad.2020.01.056 |
0.12 |
|
| 2019 |
Pariser DM, Simpson EL, Gadkari A, Bieber T, Margolis DJ, Brown M, Nelson L, Mahajan P, Reaney M, Guillemin I, Mallya UG, Eckert L. Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT). Current Medical Research and Opinion. 1. PMID 31778083 DOI: 10.1080/03007995.2019.1699516 |
0.12 |
|
| 2015 |
Papp K, Gottlieb AB, Naldi L, Pariser D, Ho V, Goyal K, Fakharzadeh S, Chevrier M, Calabro S, Langholff W, Krueger G. WITHDRAWN: Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR]). Journal of the American Academy of Dermatology. PMID 25582533 DOI: 10.1016/j.jaad.2014.10.025 |
0.119 |
|
| 2001 |
Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, Lowe NJ, Jones TM, Stewart DM, Jarratt MT, Katz I, Pariser DM, Pariser RJ, Tschen E, Chalker DK, et al. A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne Journal of the American Academy of Dermatology. 45: 187-195. PMID 11464179 DOI: 10.1067/mjd.2001.115965 |
0.119 |
|
| 2016 |
Armstrong AW, Siegel MP, Bagel J, Boh EE, Buell M, Cooper KD, Callis Duffin K, Eichenfield LF, Garg A, Gelfand JM, Gottlieb AB, Koo JY, Korman NJ, Krueger GG, Lebwohl MG, ... ... Pariser DM, et al. From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis. Journal of the American Academy of Dermatology. PMID 27908543 DOI: 10.1016/j.jaad.2016.10.017 |
0.119 |
|
| 2015 |
Kimball AB, Rothman KJ, Kricorian G, Pariser D, Yamauchi PS, Menter A, Teller CF, Aras G, Accortt NA, Hooper M, Rice KC, Gelfand JM. OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results. Journal of the American Academy of Dermatology. 72: 115-22. PMID 25264239 DOI: 10.1016/J.Jaad.2014.08.050 |
0.119 |
|
| 2007 |
Menter A, Hamilton TK, Toth DP, Leung HM, Wetherill G, Hennessey B, Garovoy M, Kwon P, Pariser DM. Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb study. International Journal of Dermatology. 46: 637-48. PMID 17550570 DOI: 10.1111/j.1365-4632.2007.03158.x |
0.119 |
|
| 2023 |
Kircik LH, Alonso-Llamazares J, Bhatia N, Bukhalo M, Devani AR, Draelos ZD, DuBois J, Gooderham MJ, Kempers SE, Lain E, Lee M, Moore A, Murrell DF, Papp KA, Pariser DM, et al. Once-daily roflumilast foam 0.3% for scalp and body psoriasis: A randomized, double-blind, vehicle-controlled phase 2b study. The British Journal of Dermatology. PMID 37279795 DOI: 10.1093/bjd/ljad182 |
0.118 |
|
| 2017 |
Bissonnette R, Haydey R, Rosoph L, Lynde CW, Bukhalo M, Fowler J, Delorme I, Gagné-Henley A, Gooderham M, Poulin Y, Barber K, Jenkin P, Landells I, Pariser D. Apremilast for the treatment of moderate to severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study. Journal of the European Academy of Dermatology and Venereology : Jeadv. PMID 29055155 DOI: 10.1111/jdv.14647 |
0.118 |
|
| 1994 |
Pariser DM, Phillips PK. Basal cell carcinoma: When to treat it yourself, and when to refer Geriatrics. 49: 39-42+44. PMID 8125351 |
0.117 |
|
| 2007 |
Pariser DM, Bagel J, Gelfand JM, Korman NJ, Ritchlin CT, Strober BE, Van Voorhees AS, Young M, Rittenberg S, Lebwohl MG, Horn EJ. National Psoriasis Foundation clinical consensus on disease severity. Archives of Dermatology. 143: 239-42. PMID 17310004 DOI: 10.1001/archderm.143.2.239 |
0.117 |
|
| 2020 |
Krueger JG, Pariser D, Tyring SK, Bagel J, Alexis AF, Soung J, Armstrong AW, Muscianisi E, Kianifard F, Prasad Sarkar MR, Blauvelt A. 15340 Long-term treatment with secukinumab led to sustained clinical improvement and normalization of inflammatory markers in patients with psoriasis Journal of the American Academy of Dermatology. 83: AB37. DOI: 10.1016/j.jaad.2020.06.234 |
0.115 |
|
| 2021 |
Bissonnette R, Gottlieb AB, Langley RG, Leonardi CL, Papp KA, Pariser DM, Uy J, Lafferty KP, Langholff W, Fakharzadeh S, Berlin JA, Brouwer ES, Greenspan AJ, Strober BE. Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR. Drug Safety. PMID 34075572 DOI: 10.1007/s40264-021-01065-z |
0.115 |
|
| 2017 |
Pariser D, Bukhalo M, Guenthner S, Kempers S, Shideler S, Gold LS, Tschen E, Berg J, Ferdon MB, Dromgoole S. Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Enhanced Lotion Formulation of Halobetasol Propionate, 0.05% Versus Its Vehicle in Adult Subjects With Plaque Psoriasis. Journal of Drugs in Dermatology : Jdd. 16: 234-240. PMID 28301619 |
0.114 |
|
| 2015 |
Pariser D, Schenkel B, Carter C, Farahi K, Brown TM, Ellis CN. A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis. The Journal of Dermatological Treatment. 1-8. PMID 26138406 DOI: 10.3109/09546634.2015.1044492 |
0.114 |
|
| 2006 |
Thiboutot D, Pariser DM, Egan N, Flores J, Herndon JH, Kanof NB, Kempers SE, Maddin S, Poulin YP, Wilson DC, Hwa J, Liu Y, Graeber M. Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial. Journal of the American Academy of Dermatology. 54: 242-50. PMID 16443054 DOI: 10.1016/J.Jaad.2004.10.879 |
0.114 |
|
| 2007 |
Berger R, Barba A, Fleischer A, Leyden JJ, Lucky A, Pariser D, Rafal E, Thiboutot D, Wilson D, Grossman R, Nighland M. A double-blinded, randomized, vehicle-controlled, multicenter, parallel-group study to assess the safety and efficacy of tretinoin gel microsphere 0.04% in the treatment of acne vulgaris in adults. Cutis. 80: 152-7. PMID 17944177 |
0.113 |
|
| 2022 |
Bagel J, Nguyen TQ, Lima H, Jain N, Pariser DM, Hsu S, Yosipovitch G, Zhang H, Chao J, Bansal S, Chen Z, Richman D, Korotzer A, Ardeleanu M. Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE). Dermatology and Therapy. PMID 35590038 DOI: 10.1007/s13555-022-00742-w |
0.112 |
|
| 2023 |
Piacquadio D, Berman B, Siegel DM, Bhatia N, Brocato J, Squittieri N, Pariser DM. Treatment Satisfaction and Acceptability of 20% Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses of the Face, Scalp, and Upper Extremities. The Journal of Clinical and Aesthetic Dermatology. 16: 46-51. PMID 38125671 |
0.112 |
|
| 2018 |
Stein Gold L, Yamauchi P, Pariser D, Xu Z, Osterdal ML, Bagel J. Treatment with Fixed Combination Calcipotriol 50 ug/g and Betamethasone Dipropionate 0.5 mg/g Foam Provides Rapid and Significant Itch Relief in Patients with Psoriasis Skin the Journal of Cutaneous Medicine. 2: S24. DOI: 10.25251/SKIN.2.SUPP.24 |
0.111 |
|
| 2017 |
Glaser DA, Hebert AA, Nast A, Werschler WP, Shideler S, Green L, Mamelok RD, Drew J, Quiring J, Pariser DM. Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Axillary Hyperhidrosis Skin the Journal of Cutaneous Medicine. 1: s95. DOI: 10.25251/SKIN.1.SUPP.94 |
0.111 |
|
| 2013 |
Paul J, Foss CE, Hirano SA, Cunningham TD, Pariser DM. An open-label pilot study of apremilast for the treatment of moderate to severe lichen planus: a case series. Journal of the American Academy of Dermatology. 68: 255-61. PMID 22910104 DOI: 10.1016/j.jaad.2012.07.014 |
0.111 |
|
| 2005 |
Schecter AK, Pariser DM, Pariser RJ, Ling MR, Stewart D, Sadick NS. Randomized, double-blind, placebo-controlled study evaluating the lidocaine/tetracaine patch for induction of local anesthesia prior to minor dermatologic procedures in geriatric patients Dermatologic Surgery. 31: 287-291. PMID 15841628 |
0.111 |
|
| 2020 |
Pariser DM, Green LJ, Lain EL, Johnson JL, Grada A. Long-term Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study Skin the Journal of Cutaneous Medicine. 4: s87. DOI: 10.25251/skin.4.supp.87 |
0.11 |
|
| 2016 |
Elewski BE, Gupta AK, Rosen T, Caldwell BD, Pariser DM, Kircik LH, Bhatia N, Tosti A. Onychomycosis: Does Cure Equate to Treatment Success? Journal of Drugs in Dermatology : Jdd. 15: 626-32. PMID 27168271 |
0.11 |
|
| 2015 |
Glaser DA, Pariser DM, Hebert AA, Landells I, Somogyi C, Weng E, Brin MF, Beddingfield F. A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis. Pediatric Dermatology. PMID 26059781 DOI: 10.1111/pde.12620 |
0.109 |
|
| 1976 |
Pariser DM, Childers RC, Kechijian P, Halprin KM, Taylor JR. Intravenous Desensitization to Mechlorethamine in Patients With Psoriasis Archives of Dermatology. 112: 1113-1114. DOI: 10.1001/archderm.1976.01630320023005 |
0.109 |
|
| 2004 |
Kempers S, Jarrat M, Pariser D, Carter E. Pimecrolimus cream 1% demonstrates better local tolerability than tacrolimus ointment 0.03% in pediatric patients with atopic dermatitis Journal of the American Academy of Dermatology. 50: P3. DOI: 10.1016/J.JAAD.2003.10.018 |
0.109 |
|
| 2012 |
Pariser DM, Meinking TL, Bell M, Ryan WG. Topical 0.5% ivermectin lotion for treatment of head lice. The New England Journal of Medicine. 367: 1687-93. PMID 23113480 DOI: 10.1056/NEJMoa1200107 |
0.109 |
|
| 2023 |
Saal R, Oldfield C, Bota J, Pariser R, Pariser D. Double-Blind, Placebo-Controlled Study of Onabotulinumtoxin A for the Treatment of Hailey-Hailey Disease. Journal of Drugs in Dermatology : Jdd. 22: 339-343. PMID 37026885 DOI: 10.36849/JDD.6857 |
0.108 |
|
| 2003 |
Pariser DM, Lowe NJ, Stewart DM, Jarratt MT, Lucky AW, Pariser RJ, Yamauchi PS. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: Results of a prospective randomized multicenter trial Journal of the American Academy of Dermatology. 48: 227-232. PMID 12582393 DOI: 10.1067/mjd.2003.49 |
0.108 |
|
| 2018 |
Stoff BK, Grant-Kels JM, Brodell RT, Paller AS, Perlis CS, Mostow E, Pariser D, Bercovitch L. Introducing a curriculum in ethics and professionalism for dermatology residencies. Journal of the American Academy of Dermatology. 78: 1032-1034. PMID 29678377 DOI: 10.1016/j.jaad.2017.04.1121 |
0.107 |
|
| 1987 |
Pariser RJ, Pariser DM. Primary care physicians' errors in handling cutaneous disorders. A prospective survey Journal of the American Academy of Dermatology. 17: 239-245. PMID 3624563 |
0.107 |
|
| 2021 |
Strober B, Pariser D, Deren-Lewis A, Dickerson TJ, Lebwohl M, Menter A. A Survey of Community Dermatologists Reveals the Unnecessary Impact of Trial-and-Error Behavior on the Psoriasis Biologic Treatment Paradigm. Dermatology and Therapy. PMID 34275121 DOI: 10.1007/s13555-021-00573-1 |
0.107 |
|
| 2019 |
Simpson E, Eckert L, Gadkari A, Mallya UG, Yang M, Nelson L, Brown M, Reaney M, Mahajan P, Guillemin I, Boguniewicz M, Pariser D. Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis. Bmc Dermatology. 19: 15. PMID 31690295 DOI: 10.1186/S12895-019-0095-3 |
0.106 |
|
| 2008 |
Piette WW, Taylor S, Pariser D, Jarratt M, Sheth P, Wilson D. Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris. Archives of Dermatology. 144: 1564-70. PMID 19075138 DOI: 10.1001/archdermatol.2008.518 |
0.106 |
|
| 2014 |
Kimball AB, Schenfeld J, Accortt NA, Anthony MS, Rothman KJ, Pariser D. Incidence rates of malignancies and hospitalized infectious events in patients with psoriasis with or without treatment and a general population in the U.S.A.: 2005-09. The British Journal of Dermatology. 170: 366-73. PMID 24251402 DOI: 10.1111/Bjd.12744 |
0.106 |
|
| 2017 |
Pariser DM, Krishnaraja J, Tremblay TM, Rubison RM, Love TW, McGraw BF. Randomized, Placebo- and Active-Controlled Crossover Study of the Safety and Efficacy of THVD-102, a Fixed-dose Combination of Oxybutynin and Pilocarpine, in Subjects With Primary Focal Hyperhidrosis. Journal of Drugs in Dermatology : Jdd. 16: 127-132. PMID 28300854 |
0.106 |
|
| 2018 |
Lebwohl MG, Sugarman JL, Gold LS, Pariser DM, Lin T, Pillai R, Martin G, Harris S, Israel R. Long-term safety results from a Phase 3 open-label study of a fixed combination halobetasol propionate 0.01% and tazarotene 0.045% (HP/TAZ) lotion in moderate-to-severe plaque psoriasis. Journal of the American Academy of Dermatology. PMID 30227193 DOI: 10.1016/j.jaad.2018.09.002 |
0.106 |
|
| 2018 |
Pariser DM, Wendelken ME, Rycerz AM, Gellings Lowe N, Yost JM, Lipner SR. Planimetric Post-hoc Analysis of Women With Onychomycosis from Tavaborole 5% Phase III Studies: Evidence of Greater Improvements in Patients With >50% Baseline Infection. Journal of Drugs in Dermatology : Jdd. 17: 168-172. PMID 29462224 |
0.106 |
|
| 2021 |
Feldman SR, Merola JF, Pariser DM, Zhang J, Zhao Y, Mendelsohn AM, Gottlieb AB. Clinical Implications and Predictive Values of Early PASI Responses to Tildrakizumab in Patients with Moderate-to-Severe Plaque Psoriasis. The Journal of Dermatological Treatment. 1-19. PMID 33678106 DOI: 10.1080/09546634.2021.1898528 |
0.106 |
|
| 2008 |
Lebwohl M, Bagel J, Gelfand JM, Gladman D, Gordon KB, Hsu S, Kalb RE, Kimball AB, Korman NJ, Krueger GG, Mease P, Morison WL, Paller A, Pariser DM, Ritchlin C, et al. From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis. Journal of the American Academy of Dermatology. 58: 94-105. PMID 17980456 DOI: 10.1016/J.Jaad.2007.08.030 |
0.105 |
|
| 2015 |
Pariser DM. Daisy Maude Orleman Robinson: the first American woman dermatologist. Clinics in Dermatology. 33: 396-406. PMID 25889142 DOI: 10.1016/j.clindermatol.2014.10.018 |
0.105 |
|
| 2019 |
Gooderham M, Elewski BE, Pariser DM, Sofen H, Mendelsohn AM, Rozzo SJ, Li Q. Incidence of serious gastrointestinal events among tildrakizumab-treated patients with psoriasis: Letter to the Editor. Journal of the European Academy of Dermatology and Venereology : Jeadv. 33: e350-e352. PMID 31033068 DOI: 10.1111/jdv.15643 |
0.104 |
|
| 2017 |
Glaser DA, Hebert AA, Fehnel S, DiBenedetti D, Nelson L, Drew J, Pariser DM. Confirmatory Psychometric Evaluation of the Axillary Sweating Daily Diary: A Vaildated Patient-Reported Outcome Measure to Assess Axillary Hyperhidrosis Sweating Severity Skin the Journal of Cutaneous Medicine. 1: s94. DOI: 10.25251/SKIN.1.SUPP.93 |
0.103 |
|
| 2021 |
Pariser DM, Lain EL, Mamelok RD, Drew J, Mould DR. Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis. Clinical Pharmacokinetics. PMID 33433785 DOI: 10.1007/s40262-020-00975-y |
0.103 |
|
| 2015 |
Menter A, Papp K, Krueger G, Augustin M, Kerdel F, Gooderham M, Goyal K, Fakharzadeh S, Langholff W, Sermon J, Calabro S, Pariser D. SAT0561 Persistence of Biologic Therapy in Psoriatic Disease: Results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) Annals of the Rheumatic Diseases. 74: 863.1-863. DOI: 10.1136/ANNRHEUMDIS-2015-EULAR.3453 |
0.103 |
|
| 1998 |
Ling MR, Swinyer LJ, Jarratt MT, Falo L, Monroe EW, Tharp M, Kalivas J, Weinstein GD, Asarch RG, Drake L, Martin AG, Leyden JJ, Cook J, Pariser DM, Pariser R, et al. Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail. Journal of the American Academy of Dermatology. 38: S95-102. PMID 9631991 DOI: 10.1016/S0190-9622(98)70492-X |
0.102 |
|
| 2023 |
Pariser DM. Building a Group Practice and Going Big. Dermatologic Clinics. 41: 635-641. PMID 37718021 DOI: 10.1016/j.det.2023.05.002 |
0.102 |
|
| 1995 |
Pariser R, Pariser D. Clinical and mycological effect of clotrimazole/betamethasone dipropionate cream versus ketoconazole cream in patients with tinea cruris Journal of Dermatological Treatment. 6: 173-177. DOI: 10.3109/09546639509097178 |
0.101 |
|
| 2017 |
Winkelmann RR, Farberg AS, Glazer AM, Cockerell CJ, Sober AJ, Siegel DM, Leachman SA, High WA, Markowitz O, Berman B, Pariser DM, Goldenberg G, Rosen T, Rigel DS. Integrating Skin Cancer-Related Technologies into Clinical Practice. Dermatologic Clinics. 35: 565-576. PMID 28886814 DOI: 10.1016/J.Det.2017.06.018 |
0.1 |
|
| 2019 |
Augustin M, Thaci D, Eyerich K, Pinter A, Radtke M, Lauffer F, Mrowietz U, Gerdes S, Pariser D, Lebwohl M, Sieder C, Melzer N, Reich K. Continued treatment with secukinumab is associated with high retention or regain of response. The British Journal of Dermatology. PMID 30972746 DOI: 10.1111/bjd.17991 |
0.1 |
|
| 2017 |
Pariser DM, Hebert AA, Drew J, Quiring J, Glaser DA. Patient-Reported Outcomes from Two Randomized, Double-Blind, Vehicle-Controlled Phase 3 Trials in Axillary Hyperhidrosis (ATMOS-1 & ATMOS-2) Skin the Journal of Cutaneous Medicine. 1: s96. DOI: 10.25251/SKIN.1.SUPP.95 |
0.098 |
|
| 1996 |
Drake LA, Dinehart SM, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Goldman MP, Duffy DM, Sadick NS, et al. Guidelines of care for sclerotherapy treatment of varicose and telangiectatic leg veins Journal of the American Academy of Dermatology. 34: 523-528. PMID 8609276 DOI: 10.1016/S0190-9622(96)90467-3 |
0.098 |
|
| 2019 |
Bruin G, Hasselberg A, Koroleva I, Milojevic J, Calonder C, Soon R, Woessner R, Pariser DM, Boutouyrie-Dumont B. Secukinumab treatment does not alter the pharmacokinetics of the CYP3A4 substrate midazolam in patients with moderate to severe psoriasis. Clinical Pharmacology and Therapeutics. PMID 31228872 DOI: 10.1002/cpt.1558 |
0.097 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hardinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Elewski BE, Elgart ML, et al. Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. Guidelines/Outcomes Committee. American Academy of Dermatology. Journal of the American Academy of Dermatology. 34: 282-6. PMID 8642094 DOI: 10.1016/S0190-9622(96)80135-6 |
0.097 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Elewski BE, Elgart ML, et al. Guidelines of care for superficial mycotic infections of the skin: tinea capitis and tinea barbae. Guidelines/Outcomes Committee. American Academy of Dermatology. Journal of the American Academy of Dermatology. 34: 290-4. PMID 8642096 DOI: 10.1016/S0190-9622(96)80137-X |
0.096 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Elewski BE, Elgart ML, et al. Guidelines of care for superficial mycotic infections of the skin: Pityriasis (tinea) versicolor. Guidelines/Outcomes Committee. American Academy of Dermatology. Journal of the American Academy of Dermatology. 34: 287-9. PMID 8642095 DOI: 10.1016/S0190-9622(96)80136-8 |
0.096 |
|
| 2003 |
Pariser DM. Treating psoriasis patients with biologic agents. Managed Care (Langhorne, Pa.). 12: 50-7; discussion 57-. PMID 14723104 |
0.095 |
|
| 1998 |
Drake LA, Babel D, Stewart DM, Rich P, Ling MR, Breneman D, Scher RK, Martin AG, Pariser DM, Pariser RJ, Ellis CN, Kang S, Katz HI, McDonald CJ, Muglia J, et al. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail Journal of the American Academy of Dermatology. 38: S87-S94. PMID 9631990 |
0.095 |
|
| 2004 |
DiGiovanna JJ, Langman CB, Tschen EH, Jones T, Menter A, Lowe NJ, Eichenfield L, Hebert AA, Pariser D, Savin RP, Smith SR, Jarratt M, Rodriguez D, Chalker DK, Kempers S, et al. Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne. Journal of the American Academy of Dermatology. 51: 709-17. PMID 15523348 DOI: 10.1016/j.jaad.2004.04.032 |
0.094 |
|
| 2015 |
Kimball AB, Schenfeld J, Accortt NA, Anthony MS, Rothman KJ, Pariser D. Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United States. The British Journal of Dermatology. PMID 26265015 DOI: 10.1111/Bjd.14068 |
0.094 |
|
| 2004 |
Czernielewski J, Liu Y, Elewski BE, Fleischer AB, Pariser DM. Comparison of 15% azelaic acid gel and 0.75% metronidazole gel for the topical treatment of papulopustular rosacea [2] (multiple letters) Archives of Dermatology. 140: 1282-1283. PMID 15492198 |
0.094 |
|
| 2019 |
Bissonnette R, Maari C, Forman S, Bhatia N, Lee M, Fowler J, Tyring S, Pariser D, Sofen H, Dhawan S, Zook M, Zammit DJ, Usansky H, Denis L, Rao N, et al. The Oral JAK/SYK Inhibitor ASN002 Demonstrates Efficacy and Improves Associated Systemic Inflammation in Patients with Moderate-to-Severe Atopic Dermatitis: Results from a Randomised, Double-Blind, Placebo-Controlled Study. The British Journal of Dermatology. PMID 30919407 DOI: 10.1111/bjd.17932 |
0.093 |
|
| 2019 |
Pariser D, Lain E, Mamelok R, Drew J, Mould D. Limited Systemic Exposure with Topical Glycopyrronium Tosylate across Multiple Studies in Healthy Volunteers and Patients with Primary Axillary Hyperhidrosis Skin the Journal of Cutaneous Medicine. 3: S55. DOI: 10.25251/skin.3.supp.55 |
0.093 |
|
| 2023 |
Nestor M, Pariser D, Del Rosso J, Glaser DA, Goldberg D, Ablon G, Lorenc ZP, Santos J. The Future of Contract Research Organizations in Dermatology and Aesthetic Research. The Journal of Clinical and Aesthetic Dermatology. 15: S28-S31. PMID 36588785 |
0.093 |
|
| 2022 |
Nestor M, Pariser D, Del Rosso J, Glaser DA, Goldberg D, Ablon G, Lorenc ZP, Santos J. The Future of Contract Research Organizations in Dermatology and Aesthetic Research. The Journal of Clinical and Aesthetic Dermatology. 15: 16-19. PMID 36213607 |
0.093 |
|
| 1991 |
Pushkin AB, Pariser DB. Political and economic forces shaping regulatory accounting for troubled debt restructuring Critical Perspectives On Accounting. 2: 127-143. DOI: 10.1016/1045-2354(91)90002-U |
0.093 |
|
| 2003 |
Reilly MC, Lavin PT, Kahler KH, Pariser DM. Validation of the Dermatology Life Quality Index and the Work Productivity and Activity Impairment-Chronic Hand Dermatitis questionnaire in chronic hand dermatitis. Journal of the American Academy of Dermatology. 48: 128-30. PMID 12522383 DOI: 10.1067/mjd.2003.128 |
0.092 |
|
| 2009 |
Andrews AW, Barr JO, De Vera Barredo R, Bemben M, Bohannon RW, Brooks S, Busse M, Cegles K, Chesbro S, Chevan J, Chui K, Clark R, Darragh A, Driv Z, Dziadek T, ... ... Pariser D, et al. Editor's message: Change in the new year⋯ Journal of Geriatric Physical Therapy. 32: 147. DOI: 10.1519/00139143-200932040-00001 |
0.092 |
|
| 2018 |
Zager JS, Gastman BR, Leachman S, Gonzalez RC, Fleming MD, Ferris LK, Ho J, Miller AR, Cook RW, Covington KR, Meldi-Plasseraud K, Middlebrook B, Kaminester LH, Greisinger A, Estrada SI, ... Pariser DM, et al. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients. Bmc Cancer. 18: 130. PMID 29402264 DOI: 10.1186/s12885-018-4016-3 |
0.091 |
|
| 2016 |
Menter A, Papp KA, Gooderham M, Pariser DM, Augustin M, Kerdel FA, Fakharzadeh S, Goyal K, Calabro S, Langholff W, Chavers S, Naessens D, Sermon J, Krueger GG. Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR). Journal of the European Academy of Dermatology and Venereology : Jeadv. PMID 27027388 DOI: 10.1111/jdv.13611 |
0.09 |
|
| 2013 |
Rich P, Elewski B, Scher RK, Pariser D. Diagnosis, clinical implications, and complications of onychomycosis. Seminars in Cutaneous Medicine and Surgery. 32: S5-8. PMID 24156161 |
0.09 |
|
| 2017 |
Fowler J, Sidbury R, Zaenglein A, Pariser D, Cook-Bolden F. 003 Crisaborole ointment improves global atopic dermatitis severity: Pooled results from two phase 3 clinical trials Journal of Investigative Dermatology. 137: S193. DOI: 10.1016/J.JID.2017.07.099 |
0.09 |
|
| 2012 |
Hirano SA, Mason AR, Salkey K, Williams JV, Pariser DM. Light microscopic hair shaft analysis in ectodermal dysplasia syndromes. Pediatric Dermatology. 29: 414-20. PMID 22084904 DOI: 10.1111/j.1525-1470.2011.01606.x |
0.09 |
|
| 2020 |
Krueger JG, Pariser D, Muscianisi E, Kianifard F, Steadman J, Prasad Sarkar MR, Ehst BD, Alexis AF. 15354 Response to treatment with secukinumab in obese patients with moderate to severe psoriasis Journal of the American Academy of Dermatology. 83: AB38. DOI: 10.1016/j.jaad.2020.06.239 |
0.09 |
|
| 2004 |
Elewski BE, Fleischer, Jr AB, Pariser DM. Comparison of 15% Azelaic Acid Gel and 0.75% Metronidazole Gel for the Topical Treatment of Papulopustular Rosacea—Reply Archives of Dermatology. 140. DOI: 10.1001/ARCHDERM.140.10.1283 |
0.087 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Webster SB, Whitaker DC, Butler B, Lowery BJ, Raimer SA, Krafchik BR, Olsen E, et al. Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology. Journal of the American Academy of Dermatology. 35: 615-9. PMID 8859293 DOI: 10.1016/S0190-9622(96)90690-8 |
0.085 |
|
| 2000 |
Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R, Sullivan S, Daniel R, Krusinski P, Fleckman P, Rich P, Odom R, Aly R, Pariser D, Zaiac M, et al. A large-scale North American study of fungal isolates from nails: The frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns Journal of the American Academy of Dermatology. 43: 641-648. PMID 11004620 |
0.085 |
|
| 2007 |
Elewski BE, Fleischer A, Pariser D. In reference to the October 2004 comprehensive overview of rosacea therapy. Journal of the American Academy of Dermatology. 57: 728. PMID 17870440 DOI: 10.1016/j.jaad.2006.11.026 |
0.085 |
|
| 2015 |
Valenzuela F, Papp KA, Pariser D, Tyring SK, Wolk R, Buonanno M, Wang J, Tan H, Valdez H. Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis. Bmc Dermatology. 15: 8. PMID 25951857 DOI: 10.1186/s12895-015-0025-y |
0.085 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Elewski BE, Elgart ML, et al. Guidelines of care for superficial mycotic infections of the skin: Mucocutaneous candidiasis Journal of the American Academy of Dermatology. 34: 110-115. PMID 8543679 DOI: 10.1016/S0190-9622(96)90842-7 |
0.084 |
|
| 2010 |
Nett B, Brosky JA, Velarde L, Pariser DP, Boyce DA. Selected Musculoskeletal and Performance Characteristics of Members of a Women's Professional Football Team: Application of a Pre-participation Examination. North American Journal of Sports Physical Therapy : Najspt. 5: 1-15. PMID 21509153 |
0.083 |
|
| 2019 |
Feldman S, Merola J, Pariser D, Zhang J, Zhao Y, Parno J, Mendelsohn A, Lowry S, Gottlieb A. PBI34 PREDICTIVE VALUE OF EARLY PASI RESPONSE TO TILDRAKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS Value in Health. 22: S53. DOI: 10.1016/J.JVAL.2019.04.116 |
0.083 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Elewski BE, Elgart ML, et al. Guidelines of care for superficial mycotic infections of the skin: Onychomycosis Journal of the American Academy of Dermatology. 34: 116-121. PMID 8543680 DOI: 10.1016/S0190-9622(96)90843-9 |
0.082 |
|
| 2003 |
Pariser DM. Management of moderate to severe plaque psoriasis with biologic therapy. Managed Care (Langhorne, Pa.). 12: 36-44. PMID 12747028 |
0.082 |
|
| 2003 |
Callen JP, Krueger GG, Lebwohl M, McBurney EI, Mease P, Menter A, Paller AS, Pariser DM, Weinblatt M, Zimmerman G. AAD consensus statement on psoriasis therapies. Journal of the American Academy of Dermatology. 49: 897-9. PMID 14576671 DOI: 10.1016/S0190-9622(03)01870-X |
0.082 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Elewski BE, Elgart ML, et al. Guidelines of care for superficial mycotic infections of the skin: Piedra Journal of the American Academy of Dermatology. 34: 122-124. PMID 8543681 DOI: 10.1016/S0190-9622(96)90844-0 |
0.082 |
|
| 1989 |
Pariser DM. Diagnostic and therapeutic techniques. For evaluation and treatment of skin disorders Primary Care - Clinics in Office Practice. 16: 823-845. PMID 2678182 |
0.081 |
|
| 2021 |
Papp KA, Lebwohl MG, Kircik LH, Pariser DM, Strober B, Krueger GG, Berk DR, Navale L, Higham RC. The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area Score. Dermatology and Therapy. PMID 34236691 DOI: 10.1007/s13555-021-00572-2 |
0.081 |
|
| 2008 |
Pariser D, Loss R, Jarratt M, Abramovits W, Spencer J, Geronemus R, Bailin P, Bruce S. Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study. Journal of the American Academy of Dermatology. 59: 569-76. PMID 18707799 DOI: 10.1016/j.jaad.2008.05.031 |
0.08 |
|
| 2010 |
Sayre R, Pariser D, Goldberg D, Geronemus R, Gottschalk R, Dowdy J. P71 Choosing an alternate light source with a corresponding dose in photodynamic therapy (it's not rocket science, but it is quantum physics!): determining the PpIX activiation effect Melanoma Research. 20: e74. DOI: 10.1097/01.CMR.0000382905.88962.A7 |
0.08 |
|
| 2012 |
Pariser DM. Ethical considerations in health care reform: pros and cons of the Affordable Care Act. Clinics in Dermatology. 30: 151-5. PMID 22330657 DOI: 10.1016/j.clindermatol.2011.06.001 |
0.08 |
|
| 2020 |
Engelman D, Yoshizumi J, Hay RJ, Osti M, Micali G, Norton S, Walton S, Boralevi F, Bernigaud C, Bowen AC, Chang AY, Chosidow O, Estrada-Chavez G, Feldmeier H, Ishii N, ... ... Pariser D, et al. The 2020 IACS Consensus Criteria for the Diagnosis of Scabies. The British Journal of Dermatology. PMID 32034956 DOI: 10.1111/bjd.18943 |
0.079 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Sontheimer RD, Callen JP, et al. Guidelines of care for cutaneous lupus erythematosus. American Academy of Dermatology. Journal of the American Academy of Dermatology. 34: 830-6. PMID 8632082 DOI: 10.1016/S0190-9622(96)90039-0 |
0.079 |
|
| 2001 |
Barbier S, Pariser D, Arbit D, Sevilla C, Flack M. The consistent effects of a low-dose oral contraceptive in the treatment of women with moderate acne vulgaris across age and race. Fertility and Sterility. 76: S53-S54. DOI: 10.1016/S0015-0282(01)02174-4 |
0.079 |
|
| 2016 |
Pariser DM, Houlihan A, Ferdon MB, Berg JE. Randomized Vehicle-Controlled Study of Short Drug Incubation Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses of the Face or Scalp. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 26863596 DOI: 10.1097/DSS.0000000000000630 |
0.078 |
|
| 2017 |
Pariser DM, Hebert AA, Drew J, Quiring J, Glaser DA. Burden of Axillary Hyperhidrosis Using a Patient-Reported Outcome Measure to Assess Impact on Activities and Bothersomeness Skin the Journal of Cutaneous Medicine. 1: s93. DOI: 10.25251/skin.1.supp.92 |
0.078 |
|
| 2005 |
Berman B, Flores J, Pariser D, Pariser R, De Araujo T, Ramirez CC. Self-warming lidocaine/tetracaine patch effectively and safely induces local anesthesia during minor dermatologic procedures Dermatologic Surgery. 31: 135-138. PMID 15762203 DOI: 10.1111/J.1524-4725.2005.31033 |
0.077 |
|
| 1996 |
Pariser DM, Pariser RJ, Breneman D, Lebwohl M, Kalb R, Moore J, Moss H, Parker C, Fiedler V. Calcipotriene ointment applied once a day for psoriasis: A double- blind, multicenter, placebo-controlled study Archives of Dermatology. 132: 1527. PMID 8961897 |
0.077 |
|
| 1980 |
Pariser DM, Wyles RJ. Toxic hepatitis from oral methoxsalen photochemotherapy (PUVA) Journal of the American Academy of Dermatology. 3: 248-250. PMID 7451691 |
0.077 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Turner ML, Webster SB, Whitaker DC, Lowery BJ, Nordlund JJ, Grimes PE, et al. Guidelines of care for vitiligo. American Academy of Dermatology. Journal of the American Academy of Dermatology. 35: 620-6. PMID 8859294 DOI: 10.1016/S0190-9622(96)90691-X |
0.072 |
|
| 2013 |
Scher RK, Rich P, Pariser D, Elewski B. The epidemiology, etiology, and pathophysiology of onychomycosis. Seminars in Cutaneous Medicine and Surgery. 32: S2-4. PMID 24156160 |
0.072 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Webster SB, Whitaker DC, Butler B, Lowery BJ, Price VH, Baden H, DeVillez RL, et al. Guidelines of care for androgenetic alopecia. American Academy of Dermatology. Journal of the American Academy of Dermatology. 35: 465-9. PMID 8784287 DOI: 10.1016/S0190-9622(96)90627-1 |
0.072 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Sontheimer RD, Callen JP, et al. Guidelines of care for dermatomyositis. American Academy of Dermatology. Journal of the American Academy of Dermatology. 34: 824-9. PMID 8632081 DOI: 10.1016/S0190-9622(96)90037-7 |
0.07 |
|
| 2019 |
Bissonnette R, Maari C, Forman S, Bhatia N, Lee M, Fowler J, Tyring S, Pariser D, Sofen H, Dhawan S, Zook M, Zammit D, Usansky H, Denis L, Rao N, et al. ASN002 demonstrates efficacy and improves inflammation in AD British Journal of Dermatology. 181. DOI: 10.1111/bjd.18398 |
0.07 |
|
| 2005 |
Pariser D, O'Hanlon A. Effects of telephone intervention on arthritis self-efficacy, depression, pain, and fatigue in older adults with arthritis Journal of Geriatric Physical Therapy (2001). 28: 67-73. PMID 16386168 |
0.069 |
|
| 1995 |
Drake LA, Dinehart SM, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Turner ML, Webster SB. Guidelines of care for local and regional anesthesia in cutaneous surgery. Guidelines/Outcomes Committee: American Academy of Dermatology. Journal of the American Academy of Dermatology. 33: 504-9. PMID 7657874 |
0.069 |
|
| 1981 |
Pariser DM. Photochemotherapy for psoriasis: A two-year study Virginia Medical. 108: 534-536+548. PMID 7293383 |
0.069 |
|
| 2007 |
Hanifin JM, Reed ML, Drake LA, Koo J, Lebwohl MG, Leung DYM, McAlister RO, Pariser DM, Weiss ST. A population-based survey of eczema prevalence in the United States Dermatitis. 18: 82-91. PMID 17498413 DOI: 10.2310/6620.2007.06034 |
0.069 |
|
| 2007 |
Glaser DA, Hebert AA, Pariser DM, Solish N. Cutis: Introduction Cutis. 79: 3-4. |
0.066 |
|
| 2009 |
Pariser D, Spencer J, Berman B, Bruce S, Parr L, Gross K. Using a hydroquinone/tretinoin-based skin care system before and after electrodesiccation and curettage of superficial truncal basal cell carcinoma Journal of Clinical and Aesthetic Dermatology. 2: 38-43. |
0.064 |
|
| 2009 |
Faul AC, Yankeelov PA, Rowan NL, Gillette P, Nicholas LD, Borders KW, Deck S, Pariser D, Wiegand M. Impact of geriatric assessment and self-management support on community-dwelling older adults with chronic illnesses. Journal of Gerontological Social Work. 52: 230-49. PMID 19308829 DOI: 10.1080/01634370802609288 |
0.063 |
|
| 2011 |
Rohrich RJ, Hanke CW, Busso M, Carruthers A, Carruthers J, Fagien S, Fitzgerald R, Glogau R, Greenberger PE, Lorenc ZP, Marmur ES, Monheit GD, Pusic A, Rubin MG, Rzany B, ... ... Pariser DM, et al. Facial soft-tissue fillers: Assessing the state of the science conference - Proceedings report Plastic and Reconstructive Surgery. 127: 9S-21S. DOI: 10.1097/PRS.0b013e31820578b9 |
0.062 |
|
| 2015 |
Pariser DM, Zachary CB. Introduction. Seminars in Cutaneous Medicine and Surgery. 34: S45. PMID 26624885 DOI: 10.12788/j.sder.2015.0147 |
0.062 |
|
| 1991 |
Pariser DB, Neidermeyer AA. Agricultural debt restructuring, accounting, and public policy: A study of the Farmers Home Administration Agriculture and Human Values. 8: 56-71. DOI: 10.1007/BF01530655 |
0.062 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Sontheimer RD, Callen JP, et al. Guidelines of care for scleroderma and sclerodermoid disorders. American Academy of Dermatology. Journal of the American Academy of Dermatology. 35: 609-14. PMID 8859292 DOI: 10.1016/S0190-9622(96)90689-1 |
0.061 |
|
| 2020 |
Stein Gold L, Lebwohl M, Papp K, Gooderham M, Kircik L, Draelos Z, Kempers S, Pariser D, Alonso-Llamazares J, Toth D, Smith K, Higham R, Navale L, Welgus H, Berk D. Roflumilast Cream (ARQ-151) Improved Itch Severity and Itch-Related Sleep Loss in Adults With Chronic Plaque Psoriasis in a Phase 2b Study Skin the Journal of Cutaneous Medicine. 4: s71. DOI: 10.25251/skin.4.supp.71 |
0.061 |
|
| 1995 |
Guidelines/Outcomes Committee, Drake LA, Ceilley RI, Cornelison RL, Dinehart SM, Dorner W, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Salasche SJ, Skouge JW, Chanco Turner ML, Webster SB, et al. Guidelines of care for office surgical facilities. Part II. Self-Assessment checklist Journal of the American Academy of Dermatology. 33: 265-270. PMID 7622655 DOI: 10.1016/0190-9622(95)90260-0 |
0.06 |
|
| 1995 |
Committee on Guidelines of Care, Drake LA, Dorner W, Goltz RW, Graham GF, Lewis CW, Pariser DM, Salasche SJ, Skouge JW, Chanco Turner ML, Lowery BJ, Task Force on Contact Dermatitis, Rietschel RL, Adams RM, Daily AD, et al. Guidelines of care for contact dermatitis Journal of the American Academy of Dermatology. 32: 109-113. PMID 7822498 DOI: 10.1016/0190-9622(95)90194-9 |
0.057 |
|
| 2013 |
Elewski BE, Rich P, Tosti A, Pariser DM, Scher R, Daniel RC, Gupta AK. Onchomycosis: an overview. Journal of Drugs in Dermatology : Jdd. 12: s96-103. PMID 23884508 |
0.056 |
|
| 1995 |
Committee on Guidelines of Care, Drake LA, Ceilley RI, Cornelison RL, Dobes WL, Dorner W, Goltz RW, Graham GF, Lewis CW, Pariser DM, Salasche SJ, Skouge JW, Chanco Turner ML, Lowery BJ, Barron DR, et al. Guidelines of care for nevi. II. Nonmelanocytic nevi, hamartomas, neoplasms, and potentially malignant lesions Journal of the American Academy of Dermatology. 32: 104-108. PMID 7822497 DOI: 10.1016/0190-9622(95)90193-0 |
0.055 |
|
| 1995 |
Guidelines/Outcomes Committee, Drake LA, Dinehart SM, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Salasche SJ, Skouge JW, Chanco Turner ML, Webster SB, Whitaker DC, Butler B, Lowery BJ, et al. Guidelines of care for chemical peeling Journal of the American Academy of Dermatology. 33: 497-503. PMID 7657873 |
0.055 |
|
| 2013 |
Pariser D, Elewski B, Rich P, Scher RK. Onychomycosis information for patients. Seminars in Cutaneous Medicine and Surgery. 32: 2p. following S9-12. PMID 24156164 |
0.055 |
|
| 1989 |
Pariser DB, Khilji NM. Monopsony and federal coal leasing - a bargaining approach Energy Economics. 11: 169-174. DOI: 10.1016/0140-9883(89)90021-2 |
0.054 |
|
| 1978 |
Pariser DM. Mycosis Fungoides Involving the Brain and Optic Nerves Archives of Dermatology. 114: 397-399. PMID 629577 DOI: 10.1001/archderm.1978.01640150033010 |
0.053 |
|
| 1994 |
Phillips PK, Pariser DM, Pariser RJ. Cosmetic procedures we all perform Cutis. 53: 187-191. PMID 8200225 |
0.052 |
|
| 1997 |
Eichenfield LF, Levy ML, Paller AS, Riccardi VM, Farmer ER, Chuang TY, Dinehart SM, Graham GF, Hordinsky MK, O'Donoghue MN, Pariser DM, Webster SB, Whitaker DC, Lowery BJ. Guidelines of care for neurofibromatosis type 1 Journal of the American Academy of Dermatology. 37: 625-630. PMID 9344204 DOI: 10.1016/S0190-9622(97)70182-8 |
0.051 |
|
| 2015 |
Hirano-Ali SA, Reed AM, Rowan BJ, Sorrells T, Williams JV, Pariser DM, Hood AF, Salkey K. Scanning Electron Microscopic Hair Shaft Analysis in Ectodermal Dysplasia Syndromes. Pediatric Dermatology. 32: 836-44. PMID 26584693 DOI: 10.1111/pde.12674 |
0.049 |
|
| 2006 |
PARISER DM. Stand Together to Tackle Workforce Issues Skin & Allergy News. 37: 12. DOI: 10.1016/S0037-6337(06)71232-3 |
0.047 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Turner MLC, Chanco Turner ML, Webster SB, Whitaker DC, Butler B, Lowery BJ, et al. Guidelines of care for nail disorders Journal of the American Academy of Dermatology. 34: 529-533. PMID 8609277 DOI: 10.1016/S0190-9622(96)90468-5 |
0.047 |
|
| 1995 |
Guidelines/Outcomes Committee, Drake LA, Dinehart SM, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Salasche SJ, Skouge JW, Chanco Turner ML, Webster SB, Whitaker DC, Butler B, Lowery BJ. Guidelines of care for Mohs micrographic surgery Journal of the American Academy of Dermatology. 33: 271-278. PMID 7622656 DOI: 10.1016/0190-9622(95)90261-9 |
0.047 |
|
| 2011 |
Nuccitelli R, Nuccitelli P, Li C, Narsing S, Pariser DM, Lui K. The electric field near human skin wounds declines with age and provides a noninvasive indicator of wound healing. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 19: 645-55. PMID 22092802 DOI: 10.1111/J.1524-475X.2011.00723.X |
0.047 |
|
| 2016 |
Glaser DA, Ballard AM, Hunt NL, Pieretti LJ, Pariser DM. Prevalence of Multifocal Primary Hyperhidrosis and Symptom Severity Over Time: Results of a Targeted Survey. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 42: 1347-1353. PMID 27879523 DOI: 10.1097/DSS.0000000000000949 |
0.045 |
|
| 2013 |
Pariser DM, Meinking TL, Ryan WG. Topical ivermectin lotion for head lice. The New England Journal of Medicine. 368: 967. PMID 23465113 DOI: 10.1056/NEJMc1215548 |
0.043 |
|
| 1999 |
Drake L, Hordinsky M, Fiedler V, Swinehart J, Unger WP, Cotterill PC, Thiboutot DM, Lowe N, Jacobson C, Whiting D, Stieglitz S, Kraus SJ, Griffin EI, Weiss D, Carrington P, ... ... Pariser DM, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia Journal of the American Academy of Dermatology. 41: 550-554. DOI: 10.1016/S0190-9622(99)80051-6 |
0.043 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Turner MC, Webster SB, Whitaker DC, Butler B, Lowery BJ. Guidelines of care for complex closures, flaps, and grafts Journal of the American Academy of Dermatology. 34: 703-708. PMID 8601669 DOI: 10.1016/S0190-9622(96)80092-2 |
0.042 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Whitaker DC, Butler B, Lowery BJ. Guidelines of care for soft tissue augmentation: Collagen implants Journal of the American Academy of Dermatology. 34: 698-702. PMID 8601668 DOI: 10.1016/S0190-9622(96)80091-0 |
0.042 |
|
| 1970 |
Pariser DM, Pittard WB. Primary isolation of Neisseria gonorrhoeae on hemoglobin-free Thayer-Martin medium Public Health Reports. 85: 532-534. PMID 4987774 |
0.038 |
|
| 1996 |
Pariser DM. Capitation for dermatologists Archives of Dermatology. 132: 1113-1116. PMID 8795557 DOI: 10.1001/archderm.132.9.1113 |
0.037 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Whitaker DC, Butler B, Lowery BJ. Guidelines of care for soft tissue augmentation: Fat transplantation Journal of the American Academy of Dermatology. 34: 690-694. PMID 8601666 DOI: 10.1016/S0190-9622(96)80089-2 |
0.037 |
|
| 2003 |
Pariser DM. The age of biologics: we've never seen anything like this. Managed Care (Langhorne, Pa.). 12: 1 p preceding table . PMID 18564552 |
0.036 |
|
| 1996 |
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Whitaker DC, Butler B, Lowery BJ. Guidelines of care for soft tissue augmentation: Gelatin matrix implant Journal of the American Academy of Dermatology. 34: 695-697. PMID 8601667 DOI: 10.1016/S0190-9622(96)80090-9 |
0.036 |
|
| 1999 |
Drake L, Hordinsky M, Fiedler V, Swinehart J, Unger WP, Cotterill PC, Thiboutot DM, Lowe N, Jacobson C, Whiting D, Stieglitz S, Kraus SJ, Griffin EI, Weiss D, Carrington P, ... ... Pariser DM, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. Journal of the American Academy of Dermatology. 41: 550-4. PMID 10495374 |
0.035 |
|
| 1999 |
Pariser DA. Looking for the muse in some of the right places American Journal of Education. 107: 155-169. |
0.03 |
|
| 2013 |
Pariser D. The rationale for renewed attention to onychomycosis. Seminars in Cutaneous Medicine and Surgery. 32: S1. PMID 24156159 |
0.027 |
|
| 2014 |
Pariser DM. Hyperhidrosis. Dermatologic Clinics. 32: xi. PMID 25152352 DOI: 10.1016/j.det.2014.07.001 |
0.025 |
|
| 2003 |
Lebwohl M, Tyring SK, Hamilton TK, Toth D, Glazer S, Tawfik NH, Walicke P, Dummer W, Wang X, Garovoy MR, Pariser D. A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. The New England Journal of Medicine. 349: 2004-13. PMID 14627785 DOI: 10.1056/NEJMoa030002 |
0.022 |
|
| 2015 |
Hirano-Ali SA, Reed AM, Rowan BJ, Sorrells T, Williams JV, Pariser DM, Hood AF, Salkey K. Scanning Electron Microscopic Hair Shaft Analysis in Ectodermal Dysplasia Syndromes Pediatric Dermatology. DOI: 10.1111/pde.12674 |
0.021 |
|
| 1976 |
Pariser RJ, Pariser DM. Quinidine photosensitivity Archives of Dermatology. 112: 1610-1611. PMID 984868 DOI: 10.1001/archderm.112.11.1610 |
0.019 |
|
| 1989 |
Pariser D, Armstrong J. The Binary Bible Leonardo. 22: 455. DOI: 10.2307/1575446 |
0.01 |
|
| 1987 |
Pariser DB. Agricultural real estate loans and secondary markets Agriculture and Human Values. 4: 29-39. DOI: 10.1007/BF01530639 |
0.01 |
|
| Hide low-probability matches. |